Stock Earnings

Question 1

Scinai Immunotherapeutics Ltdの主要な財務諸表は何ですか？

Accepted Answer

最新の財務諸表（Form-10K）によると、Scinai Immunotherapeutics Ltdの総資産は$13で、純profitは$4です。

Question 2

SCNIの主要な財務比率は何ですか？

Accepted Answer

Scinai Immunotherapeutics Ltdの流動比率は4.33、純利益率は0、1株当たり売上高は$0です。

Question 3

Scinai Immunotherapeutics Ltdの収益はセグメントまたは地域別にどのように分けられていますか？

Accepted Answer

Currently Scinai Immunotherapeutics Ltd data is not available.

Question 4

Scinai Immunotherapeutics Ltdは収益を上げていますか？

Accepted Answer

yes、最新の財務諸表によると、Scinai Immunotherapeutics Ltdの純profitは$4です。

Question 5

Scinai Immunotherapeutics Ltdに負債はありますか？

Accepted Answer

yes、Scinai Immunotherapeutics Ltdの負債は3です。

Question 6

Scinai Immunotherapeutics Ltdの発行済株式数は何株ですか？

Accepted Answer

Scinai Immunotherapeutics Ltdの総発行済株式数は3,411.98株です。

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	1	0	0	0	0	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	2	1	--	--	--	--
Gross Profit	-1	0	--	--	--	--
Selling, General & Admin	2	2	4	5	7	4
Research & Development	3	5	5	5	2	14
Operating Expenses	-7	8	9	11	10	-2
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	4	4	-6	-5	-12	-1
Income Tax Expense	--	--	--	--	--	--
Net Income	4	4	-6	-5	-12	-1
Net Income Growth	-200%	-167%	20%	-57.99%	1,100%	-97%
Shares Outstanding (Diluted)	6,364.73	3,225.47	1,562.62	754.07	56.45	44.32
Shares Change (YoY)	111%	106%	107%	1,236%	27%	36%
EPS (Diluted)	0	0	0	-0.01	-0.22	-0.03
EPS Growth	-191%	--	-100%	-95%	633%	-97%
Free Cash Flow	-5	-6	-10	-8	-7	-22
Free Cash Flow Per Share	0	0	0	-0.01	-0.12	-0.49
Gross Margin	-100%	0%	--	--	--	--
Operating Margin	600%	0%	0%	0%	0%	0%
Profit Margin	400%	0%	0%	0%	0%	0%
Free Cash Flow Margin	-500%	0%	0%	0%	0%	0%
EBITDA	7	-7	-9	-11	-10	2
EBITDA Margin	700%	0%	0%	0%	0%	0%
D&A For EBITDA	1	1	0	0	0	0
EBIT	6	-8	-9	-11	-10	2
EBIT Margin	600%	0%	0%	0%	0%	0%
Effective Tax Rate	--	--	--	--	--	--

Scinai Immunotherapeutics Ltd (SCNI) Price